Back to Screener

Healthcare

FONAR Corporation(FONR)

Live Price

Offline

$19.09

+0.00% today

1Y Change

+32.39%

Window

Jun 26, 2025 โ†’ Jun 3, 2026

Market Cap
$120.00M
Revenue Growth
+1.4%
EPS Growth
-19.2%
Dividend Yield
0.0%

Coverage: 235 bars ยท Jun 26, 2025 โ†’ Jun 3, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

FONAR Corporation (FONR) is a Healthcare stock with a market cap of $120.00M and listed on NASDAQ. The stock last traded around $19.09 and up 32.4% across the available one-year price window (Jun 26, 2025 โ†’ Jun 3, 2026). Baseline metrics include revenue growth of +1.4%, EPS growth of -19.2%, a dividend yield of 0.0%. What stands out right now is revenue +1.4%, EPS -19.2%, free cash flow -43.9% with operating margin 10.1% and ROIC 4.0%. Valuation is more restrained than many high-expectation growth names at P/E 15.7 and price/sales 1.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines FONR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

FONR vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

FONR

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

FONR Max Drawdown

-13.98%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for FONR and SPY.

Calendar-year return history is still loading or unavailable.

EPS Consensus

0.00

Range 0.00 -> 0.00

No analyst count

Revenue Outlook

$0.0B

Range $0.0B -> $0.0B

No analyst count

Price Target

--

-- -> --

No analyst count

Recommendations

--

No recommendation feed

No date

Consensus Spread

EPS spread--
Revenue spread0.0%

Lower spread suggests tighter agreement across covering analysts.

Next Earnings

No date

EPS --

Revenue --

No analyst count

EPS Revisions

No revision signal

No recent EPS revision rows

0 revision rows

Trend

EPS trend

Consensus average across visible periods

0.00
Latest visible period
Need at least two valid points to draw a trend.

Trend

Revenue trend

Average analyst revenue estimate

$0.0B
Latest visible period
Need at least two valid points to draw a trend.

Timeline

Analyst forecast ladder

Sorted by period end date. Includes both cached rows and live fallbacks from the configured analyst feed.

Q3 2025
Ends Sep 30, 2025
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
0.00
0.00 to 0.00
No analyst count
EPS: No analyst count
Apr 26, 11:40 AM UTC
stable/analyst-estimates

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.